271 related articles for article (PubMed ID: 30973416)
1. Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
Viazis N; Pontas C; Karmiris K; Dimas I; Fragaki M; Paspatis G; Drygiannakis I; Koutroubakis IE; Moschovis D; Tzouvala M; Theocharis G; Tsolias C; Thomopoulos K; Zampeli E; Axiaris G; Michopoulos S; Belesiotou E; Banasa M; Maraki S; Kouskoumpekou F; Apostolopoulos G; Stamouli V; Prifti H; Mantzaris GJ
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):773-776. PubMed ID: 30973416
[TBL] [Abstract][Full Text] [Related]
2. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
[TBL] [Abstract][Full Text] [Related]
3. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
[TBL] [Abstract][Full Text] [Related]
4. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
[TBL] [Abstract][Full Text] [Related]
5. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
[TBL] [Abstract][Full Text] [Related]
7. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
Solanky D; Pardi DS; Loftus EV; Khanna S
Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients.
Hojsak I; Ferenc T; Bojanić K; Mišak Z; Močić Pavić A; Lukić-Grlić A; Kolaček S
Digestion; 2012; 86(1):6-11. PubMed ID: 22688504
[TBL] [Abstract][Full Text] [Related]
10. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF
Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and clinical characteristics of Clostridium difficile infection in Saudi patients admitted with inflammatory bowel disease: A case-control study.
AlKhormi A; Altheyabi AM; AlGhamdi SA; Alshahrani O; Alotay AA; Deeb A
Saudi J Gastroenterol; 2023; 29(4):251-255. PubMed ID: 37282448
[TBL] [Abstract][Full Text] [Related]
12. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
[TBL] [Abstract][Full Text] [Related]
13. Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease.
Desai M; Knight K; Gray JM; Nguyen V; Boone J; Sorrentino D
Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1099-1105. PubMed ID: 32516177
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease.
Lamousé-Smith ES; Weber S; Rossi RF; Neinstedt LJ; Mosammaparast N; Sandora TJ; McAdam AJ; Bousvaros A
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):293-7. PubMed ID: 23698022
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infections in a university hospital in Greece are mainly associated with PCR ribotypes 017 and 126.
Kachrimanidou M; Tsachouridou O; Ziogas IA; Christaki E; Protonotariou E; Metallidis S; Skoura L; Kuijper E
J Med Microbiol; 2017 Dec; 66(12):1774-1781. PubMed ID: 29087273
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
[TBL] [Abstract][Full Text] [Related]
19. Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease.
Zhang T; Lin QY; Fei JX; Zhang Y; Lin MY; Jiang SH; Wang P; Chen Y
Sci Rep; 2016 Jul; 6():29791. PubMed ID: 27417996
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
